| Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data J Ochalek, J Lomas, K Claxton BMJ global health 3 (6), e000964, 2018 | 215 | 2018 |
| Cost-effectiveness thresholds: the past, the present and the future P Thokala, J Ochalek, AA Leech, T Tong Pharmacoeconomics 36, 509-522, 2018 | 169 | 2018 |
| Cost per DALY averted thresholds for low-and middle-income countries: evidence from cross country data JM Ochalek, J Lomas, KP Claxton Centre for Health Economics, University of York, 2015 | 83 | 2015 |
| Supporting the development of a health benefits package in Malawi J Ochalek, P Revill, G Manthalu, F McGuire, D Nkhoma, A Rollinger, ... BMJ global health 3 (2), e000607, 2018 | 61 | 2018 |
| Informing a cost-effectiveness threshold for health technology assessment in China: a marginal productivity approach J Ochalek, H Wang, Y Gu, J Lomas, H Cutler, C Jin Pharmacoeconomics 38 (12), 1319-1331, 2020 | 54 | 2020 |
| What next after GDP-based cost-effectiveness thresholds? YL Chi, M Blecher, K Chalkidou, A Culyer, K Claxton, I Edoka, ... Gates open research 4, 2020 | 44 | 2020 |
| Public financial management and health service delivery: a literature review Y Goryakin, P Revill, AJ Mirelman, R Sweeney, J Ochalek, M Suhrcke Global Health Economics: Shaping Health Policy in Low-and Middle-Income …, 2020 | 28 | 2020 |
| Accounting for timing when assessing health-related policies K Claxton, M Asaria, C Chansa, J Jamison, J Lomas, J Ochalek, ... Journal of Benefit-Cost Analysis 10 (S1), 73-105, 2019 | 26 | 2019 |
| Empirical estimates of the marginal cost of health produced by a healthcare system: methodological considerations from country-level estimates LC Edney, J Lomas, J Karnon, L Vallejo-Torres, N Stadhouders, ... Pharmacoeconomics 40 (1), 31-43, 2022 | 25 | 2022 |
| Reflecting the health opportunity costs of funding decisions within value frameworks: initial estimates and the need for further research J Ochalek, J Lomas Clinical Therapeutics 42 (1), 44-59. e2, 2020 | 20 | 2020 |
| Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries J Ochalek, K Abbas, K Claxton, M Jit, J Lomas BMJ global health 5 (10), e003006, 2020 | 19 | 2020 |
| Valuing health outcomes: developing better defaults based on health opportunity costs J Ochalek, K Claxton, J Lomas, KM Thompson Expert Review of Pharmacoeconomics & Outcomes Research 21 (4), 729-736, 2021 | 18 | 2021 |
| A one stop shop for cost-effectiveness evidence? Recommendations for improving Disease Control Priorities M Arnold, S Griffin, J Ochalek, P Revill, S Walker Cost Effectiveness and Resource Allocation 17, 1-4, 2019 | 18 | 2019 |
| Cost-effectiveness thresholds: guiding health care spending for population health improvement P Revill, J Ochalek, J Lomas, R Nakamura, B Woods, A Rollinger, ... F1000Research 6 (489), 489, 2017 | 18 | 2017 |
| Supporting the development of an essential health package: principles and initial assessment for Malawi JM Ochalek, KP Claxton, P Revill, MJ Sculpher, A Rollinger | 18 | 2016 |
| Supporting a review of the benefits package of the National Health Insurance Scheme in Ghana H Vellekoop, E Odame, J Ochalek Cost Effectiveness and Resource Allocation 20 (1), 32, 2022 | 11 | 2022 |
| Avoiding opportunity cost neglect in cost-effectiveness analysis for health technology assessment J Lomas, J Ochalek, R Faria Applied Health Economics and Health Policy 20 (1), 13-18, 2022 | 11 | 2022 |
| Causal effects of HIV on employment status in low-income settings J Ochalek, P Revill, B van den Berg Economics & Human Biology 27, 248-260, 2017 | 11 | 2017 |
| Accounting for country-and time-specific values in the economic evaluation of health-related projects relevant to low-and middle-income countries J Lomas, K Claxton, J Ochalek Health Policy and Planning 37 (1), 45-54, 2022 | 10 | 2022 |
| How Much Health for the Money?: Using Cost-Effectiveness Analysis to Support Benefits Plan Decisions MJ Sculpher, P Revill, JM Ochalek, KP Claxton What’s In, What’s Out: Designing Benefits for Universal Health Coverage, 2017 | 10 | 2017 |
